8-KShareholder MattersCorporate ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Bylaw Amendment (Jun 5, 2018)

Filed June 5, 2018For Securities:CVS

Summary

This 8-K filing from CVS Health Corporation (CVS) on June 5, 2018, details the outcomes of its Annual Stockholder Meeting held on June 4, 2018. The primary focus for investors is the approval of an amendment to the company's Certificate of Incorporation, which lowers the ownership threshold required for stockholders to call a special meeting from 25% to 15% of the voting power. This change enhances shareholder rights by making it easier for a larger group of shareholders to initiate discussions and actions on significant corporate matters. Additionally, the filing confirms the election of all 12 director nominees and the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2018. Management's proposal to approve executive compensation was also passed. Importantly, a stockholder proposal seeking a by-law for confidential voting on executive pay was rejected, indicating a preference for the current disclosure practices regarding executive remuneration.

Key Highlights

  • 1CVS Health Corporation stockholders approved an amendment to reduce the ownership threshold for calling special meetings from 25% to 15% of voting power.
  • 2All 12 director nominees were elected for one-year terms at the Annual Meeting.
  • 3Ernst & Young LLP was ratified as the company's independent registered public accounting firm for 2018.
  • 4The management's proposal to approve the compensation of named executive officers received non-binding approval.
  • 5A stockholder proposal requesting a by-law for confidential voting on executive pay was rejected by a significant margin.
  • 6The company filed a Restated Certificate of Incorporation, consolidating all amendments to date.
  • 7A Certificate of Retirement was filed for Series I ESOP Convertible Preference Stock, which had no shares issued or outstanding.

Frequently Asked Questions

The most significant change for shareholders is the reduction of the ownership threshold required to call a special meeting from 25% to 15% of the company's voting power. This gives a broader group of shareholders the ability to convene a special meeting to discuss and vote on important corporate matters.

The proposal to approve, by a non-binding vote, the compensation of CVS Health's named executive officers was approved by shareholders. However, a separate stockholder proposal for a by-law regarding confidential voting on executive pay was rejected.

No, the filing indicates that all 12 nominees for the Board of Directors were elected for one-year terms, suggesting no immediate change in board composition resulting from this meeting.

No, the filing confirms the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for 2018, indicating continuity in their auditing relationship.